Navigation Links
An ITG Majestic Market Research Study Indicates a Bright Future for Gilenya, Despite Concerns About Its Safety
Date:12/17/2010

s.

On the plus side, future prospects for Gilenya look positive, as 90% of neurologists in the study reported they plan to prescribe Gilenya in the future.  "We view Gilenya's launch and future outlook in the multiple sclerosis space as very promising," said Jemma Lampkin, lead researcher on the study. "Gilenya's launch trajectory and penetration into our physician panel is encouraging.  In addition, payors have been very receptive to Gilenya thus far, which bodes well for the drug from a reimbursement standpoint."  According to ITG's interviews with pharmacy benefit managers at 10 managed care organizations, planned reimbursement restrictions for Gilenya will be similar to those required for other disease-modifying MS agents. Furthermore, the majority of interviewed managed care organizations already reimburse the drug.

Event Pulse: Launch of Gilenya  includes analysis of a targeted Internet survey of 75 neurologists, 10 in-depth telephone interviews with pharmacy directors at major managed care organizations, and proprietary longitudinal treatment data from a panel of 200 neurologists spanning 2005-2010. Conducted in November 2010, the report takes an in-depth look at how the launch of Gilenya will affect the multiple sclerosis market. In addition, Event Pulse: Launch of Gilenya  evaluates uptake and use of recently launched <
'/>"/>

SOURCE ITG
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
2. FDA Advisory Committees Recommend Continued U.S. Marketing Authorization for Trasylol(R)
3. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
4. ADVENTRX Announces Completion of Patient Enrollment in ANX-530 Marketing-Enabling Clinical Study
5. Results of TRIUMPH-1 Trial of Viveta in Pulmonary Arterial Hypertension to Be Announced Before Market Open on Thursday, November 1, 2007
6. Inverness Medical Innovations to Present at CIBC World Markets 18th Annual Healthcare Conference on November 7, 2007
7. ADVENTRX Meets Primary Endpoint in ANX-530 Marketing-Enabling Clinical Study
8. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
9. Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference
10. GE Healthcare and Novavax Establish Collaboration To Develop and Market Pandemic Influenza Solution
11. Pharmion Submits European Marketing Authorization Application (MAA) for Vidaza(R) in Patients with Higher-Risk Myelodysplastic Syndromes (MDS)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Calif. , March 2, 2015  CytomX, ... treatment of cancer, today announced the creation of ... researchers and clinicians in the fields of cancer ... The new advisory boards will provide guidance to ... pipeline of precision immunotherapies and Probody drug conjugates. ...
(Date:3/2/2015)... March 2, 2015 Leading patient advocacy organization ... the 2015 One Million Strong ... will raise awareness and funds for colorectal cancer education, ... million colorectal cancer survivors living in the ... great strength and courage every day. Showing ...
(Date:3/2/2015)... 2, 2015  The International Myeloma Foundation (IMF), ... myeloma patients while working toward prevention and a ... March to be Myeloma Awareness Month (#MAM). ... Awareness Month in 2009. Throughout the month, the ... community events, social media campaigns, story sharing, and ...
Breaking Medicine Technology:CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 2CytomX Expands Scientific and Clinical Advisory Boards with Leading Experts in Cancer Immunotherapy and Antibody Drug Conjugates 3Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 2Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 3Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 4Advocacy Group Fight Colorectal Cancer and Bayer HealthCare Join Forces for One Million Strong 5International Myeloma Foundation Declares March "Myeloma Awareness Month" 2International Myeloma Foundation Declares March "Myeloma Awareness Month" 3
... BETHLEHEM, Pa., July 12, 2011 ... and Absorption Systems, a leading provider of pre-clinical ... are working together to provide their clients with ... data into the dosage form development scheme.   ...
... UBM TechInsights, the leader in technical intelligence and ... that medical devices industry veteran Bill Betten has joined ... this role Mr. Betten will draw upon his years ... sector maximize the effectiveness of the product innovation processes ...
Cached Medicine Technology:Particle Sciences and Absorption Systems Form Relationship to Offer their Clients Enhanced Services 2UBM TechInsights Hires Medical Devices Industry Veteran Bill Betten 2
(Date:3/2/2015)... “ Wants and Needs ” was featured on NewsWatch ... latest and coolest mobile applications on the iOS, Android, ... and host of NewsWatch, conducted the app review and ... priorities. , Whether a person needs help re-orienting or ... app allows people to enter and track wants, both ...
(Date:3/2/2015)... Angeles, CA (PRWEB) March 02, 2015 ... offering gum reshaping procedures. Gum reshaping can involve one or ... or to regenerate lost gum tissue for a more even ... dark gum line treatment that can permanently lighten ... his total smile approach, which involves a personalized treatment plan ...
(Date:3/2/2015)... Va. (PRWEB) March 02, 2015 The ... nonprofit authority on the use of health IT to ... white paper, “ICD-10 Testing for Small Providers.” The white ... with a starting point for ICD-10 testing by focusing ... payers to ensure compliance with the October 1, 2015 ...
(Date:3/2/2015)... LegitScript, LLC, operator of ... including those for Internet pharmacy certification, monitoring ... classification, has launched a certification program for ... program, called iCareRx , provides certification ... identity of the owner/operator of Internet websites, ...
(Date:3/2/2015)... 2015 A true renaissance man—some might call ... 1960s cult rock band Khazad Doom, has long inspired his ... persevere despite all odds. His motto throughout his life has ... or goal was before him. And that attitude, born amidst ... passed on to a new generation. , As Eadon knows, ...
Breaking Medicine News(10 mins):Health News:An Application to Evaluate Priorities Was Featured on NewsWatch Television on January 30, 2015 2Health News:Gummy Smile Expert, Dr. Alex Farnoosh, is Now Offering Gum Reshaping Procedures 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:LegitScript Launches Certification Program for Internet Eyeglass Sellers 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 2Health News:Cult Rock Star’s “Got To Make It” Attitude Inspires New Generations 3
... a mirror of the inner self. However, according to a new ... stroke-related death. // ,The study, published in the October ... the eyes to determine whether people have a higher risk of ... tiny lesions on the back of the eye are two to ...
... A new study published in the October 17 issue of ... fight inflammation in the gut. This feature may help the ... a foreign particle//. ,Fat rich foods stimulate the ... hormone called cholecystokinin, or CCK. This enzyme is responsible for ...
... elbow has been enjoying the spot light following ace cricketer ... However, the condition is not uncommon in the sports arena//. ... called in medical parlance, is an affliction where the outer ... a result of a specific strain, overuse or a direct ...
... for cardiovascular disease in both men and women, which ... subjects and that 80 percent of all type 2 ... In these patients hyperglycemia per se confers ... of even borderline-high-risk LDL-C signals the need for more ...
... out the benefits of oral ZYVOX for the treatment ... They compared data from 80 health care clinics and ... Vancomycin. The results show that oral tablets of Linezolid ... spent to health clinics compared to vancomycin. ...
... Terminally ill people have the right to a life of ... the pain which often accompanies diseases like cancer, say experts ... // . ,Currently, only a few states like Kerala, ... have provisions that allow care-giving organisations to administer strong pain ...
Cached Medicine News:Health News:Lesions in the eyes may forecast a stroke 2Health News:Tennis elbow not new among cricketers, say experts 2Health News:Oral use of ZYVOX (Linezolid) is better to Intravenous Vancomycin use for Skin Infections 2Health News:Terminally Ill deserves a better quality of Life 2Health News:Terminally Ill deserves a better quality of Life 3
A portable, easy to use, dual-channel laser-Doppler tissue perfusion and temperature monitoring system, at a remarkably affordable price....
... high performance laser doppler system for ... blood perfusion. This latest generation single-channel ... with its multi-channel brother (Oxyflo), including ... and laser doppler flowmetry providing a ...
Transcranial vascular DWL doppler....
Transcranial vascular DWL doppler....
Medicine Products: